Rhythm Biosciences Limited (RHYTHM BIO FPO [RHY]) aksje
RHY.AX
$0.1100+0.0050 (+4.76%)
Laster graf...
RHYTHM BIO FPO [RHY]
Market Cap
$38,925,352
Åpning0.1050
Høy0.1200
Lav0.1050
Volum707.12k
P/EN/A
Markedsverdi38.93M
52-ukers høy0.2800
52-ukers lav0.0470
Gj.sn. volum611.71k
UtbytteN/A
Beta0.48
EPS-0.0200
Om Rhythm Biosciences Limited (RHYTHM BIO FPO [RHY]) aksje
Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States. It offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. The company was incorporated in 2017 and is headquartered in Parkville, Australia.
Selskapsinformasjon
Børs: ASX (ASX)
Sektor: Sundhed
Industri: Diagnostik og forskning
Adresse:
Bio21 Institute
3010 Parkville, Australia
3010 Parkville, Australia
Telefon: + 61 3 8256 2880
Nettside: https://rhythmbio.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål